At the Intersection of Biomaterials and Gene Therapy: Progress in Non-viral Delivery of Nucleic Acids
Biomaterials play a critical role in technologies intended to deliver therapeutic agents in clinical settings. Recent explosion of our understanding of how cells utilize nucleic acids has garnered excitement to develop a range of older (e.g., antisense oligonucleotides, plasmid DNA and transposons)...
Main Authors: | Hasan Uludag, Anyeld Ubeda, Aysha Ansari |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2019-06-01
|
Series: | Frontiers in Bioengineering and Biotechnology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fbioe.2019.00131/full |
Similar Items
-
Strategies for ocular siRNA delivery: Potential and limitations of non-viral nanocarriers
by: Thakur Ajit, et al.
Published: (2012-06-01) -
Progress in RNAi-mediated Molecular Therapy of Acute and Chronic Myeloid Leukemia
by: Breanne Landry, et al.
Published: (2015-01-01) -
Prospects for RNAi Therapy of COVID-19
by: Hasan Uludağ, et al.
Published: (2020-07-01) -
Delivery of Nucleic Acids and Proteins from Grafted Rootstocks for Pathogen and Pest Control
by: Victor eHaroldsen, et al.
Published: (2012-03-01) -
RNA Interference as a Prospective Tool for the Control of Human Viral Infections
by: Alesia Levanova, et al.
Published: (2018-09-01)